{"ticker": {"uuid": "fb075520-667b-4682-8423-88722001a5cb", "symbol": "MEDP", "name": "Medpace Holdings Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Why Medpace (MEDP) Dipped More Than Broader Market Today", "summary": "Medpace (MEDP) shares dipped 1.49% today, underperforming the broader market, despite an impressive 15.17% gain over the past month. Investors are eagerly anticipating its upcoming earnings report on July 22, 2026, with projected EPS up 31.61% and revenue up 15.95% year-over-year", "url": "https://sg.finance.yahoo.com/news/why-medpace-medp-dipped-more-221505743.html", "source_name": "Market source", "published_at": "2026-07-13T17:15:00", "published_display": "13 Jul 2026 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. (MEDP) Stock Analysis: Is the Current Valuation Justified Amidst Strong Revenue Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPUk9XWGVmcGdwTUU3dFhObWFFNHFDTGJjZ0RMOW9aanZJbU1EQ2VPM3A0ZlNzaGFhaTJFZ2E4dGhuekE1WkFnUHk2OG1PYnNDODdlbXMwbnRxcno0Y09KWnlGa3RUZzVISDkxQTl0dS02aXo2SnIyaWFsU2ZmVEh5dmJvRUdIbEFnWWtWWFg2Zjhuek5UeUtBcUM0MTBzMU13Y1JxMDRxRGpULWVyaGJXdnZGWVRtenNRLVR2MXVsbmF1dEVIckJNbjVkV01JLXhBR051NUxJMGVxRVlIUWY1Z2x3NEZQYzF6LWlZ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:16+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings (MEDP) Rallies As A More Cautious Narrative Questions The Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbDJPR1JEWlpESVctMnE3elZEM29mX1U3bGVGSkJnWDJ3c3BsOWVNWjFadDdZNC1HZi1yQUl0bVIyMExibFhwWUJiSU80VEJiQkJ1VnN2QWdfLXZfSXJuVTVpcUNFaXZIVzFSQkNMaW5QU2UyM09qdmNXZzhIY3FNRUZoRmEzZmsxbllGVFE0eTVTd2FhSDZvMTJpMi02Y24w?oc=5", "source_name": "Market source", "published_at": "2026-07-11T06:14:00+00:00", "published_display": "11 Jul 2026 06:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Medpace Holdings, Inc. (MEDP) regarding potential corporate wrongdoing. The firm is encouraging shareholders who purchased Medpace securities prior to April 22, 2025, and still hold them, to join the investigat", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1174536", "source_name": "ACCESS Newswire", "published_at": "2026-07-09T11:00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird downgrades Medpace stock rating to neutral, raises target to $547", "summary": "Baird has downgraded Medpace Holdings Inc. (NASDAQ:MEDP) from Outperform to Neutral, while increasing its price target to $547.00 from $477.00. The downgrade comes despite the stock's 69% surge over the past year, as its current trading price of $546 is nearly identical to Baird'", "url": "https://www.investing.com/news/analyst-ratings/baird-downgrades-medpace-stock-rating-to-neutral-raises-target-to-547-93CH-4780801", "source_name": "Investing.com", "published_at": "2026-07-09T06:39:40", "published_display": "09 Jul 2026 06:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Shares Fall After Baird Downgrade", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/medpace-shares-fall-baird-downgrade-190643265.html", "source_name": "MT Newswires", "published_at": "2026-07-08T19:06:43+00:00", "published_display": "08 Jul 2026 19:06", "sentiment": "negative", "sentiment_pct": 22, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird downgrades Medpace stock rating to neutral, raises target to $547 By Investing.com", "summary": "Baird has downgraded Medpace (NASDAQ:MEDP) stock from Outperform to Neutral, while increasing its price target to $547 from $477. The downgrade is primarily due to the stock's significant rally, now trading near Baird's new price target, and a need for the firm to substantially r", "url": "https://ng.investing.com/news/stock-market-news/baird-downgrades-medpace-stock-rating-to-neutral-raises-target-to-547-93CH-2590291", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T16:11:21", "published_display": "08 Jul 2026 16:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477", "summary": "Baird has downgraded Medpace Holdings (MEDP) from an \"Outperform\" rating to \"Neutral,\" while simultaneously increasing its price target for the company from $477 to $547. This adjustment reflects a modified outlook by the firm on Medpace's stock. The article also provides a brief", "url": "https://www.marketscreener.com/news/baird-downgrades-medpace-to-neutral-from-outperform-adjusts-pt-to-547-from-477-ce7f5ed9d980f123", "source_name": "marketscreener.com", "published_at": "2026-07-08T12:10:58", "published_display": "08 Jul 2026 12:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Medpace Holdings (MEDP) Justify Its Valuation On Backlog Quality Concerns?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNWUNSUElrdXNtQXBLRmlRS1I3LXdHZEo2a1FzenZodjd3TkNiaGNRYWRHOUxMaGpyMWdzQ0E2eV9BaGhqOVBqejA0QTI5bVVwNURzVXl2M291MVE4WTFuRHp3RjRfaHE1TmdLaXN1MlAwT2ZMLXpLdzh5TmpBeXJXamlHWkc4bVdydGlpZkw3aGdBWGRMRC1McFVIS1hoYk1rZ1BpMWtMalpoZ0ZmMHYwMVpwWVo0QmZoNk9fSlVjSkJnZ0FjeTdQOFdlTHBMR3lCekdvVzh0WVQtRXVJandlWDhINW7SAeoBQVVfeXFMUGZnMjJ4YTlNTy1aU0V0bGQyanJaYjRrSmQ1eWlqWEpCRWU3WmpienBKZWRLTUFIczlkc1VINlEwdjlxRnJkenpZc3pFVlgyUnpPYjNLcHZaTTRWb2Y0dVBPcm5mSGRuS0xrYUp3Ty1iQ1E4U01Dd0M4SHB4TXVYYzlUX01kWFJjLUVCUk43VGdUX0VoS211U2hKMzFIRzA4bVBLNHg5cVF3MkRpYnBzWXBQRFlDWE4zMXNYaHZiVDVLWTFOaE9zX2laeUV5cTVuUzFRdkNlVEhCR2FGQWQyb01kRURsVy1GNW5B?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T06:46:19+00:00", "published_display": "08 Jul 2026 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Growth Trends Show How CRO Demand Is Shifting in 2026", "summary": "Medpace Holdings (MEDP) is experiencing a shift in demand for its clinical research organization (CRO) services in 2026, with an uneven distribution across therapeutic areas and a longer conversion cycle for awards into revenue. Despite these challenges, Medpace's full-service mo", "url": "https://www.theglobeandmail.com/investing/markets/stocks/MEDP/pressreleases/3165471/medpace-growth-trends-show-how-cro-demand-is-shifting-in-2026/", "source_name": "The Globe and Mail", "published_at": "2026-07-07T18:39:43", "published_display": "07 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies downgrades Medpace stock rating on valuation concerns", "summary": "Jefferies downgraded Medpace Holdings Inc. (NASDAQ:MEDP) to Hold from Buy, citing significant valuation concerns despite raising the price target to $515.00 from $490.00. The stock is currently trading above this target, and analysts note it is overvalued, with several downward e", "url": "https://www.investing.com/news/analyst-ratings/jefferies-downgrades-medpace-stock-rating-on-valuation-concerns-93CH-4778382", "source_name": "Investing.com", "published_at": "2026-07-07T18:10:14", "published_display": "07 Jul 2026 18:10", "sentiment": "negative", "sentiment_pct": 26, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Shares Fall After Jefferies Downgrade", "summary": "Medpace Holdings, Inc. shares dropped following a downgrade from Jefferies. The article, published on July 7, 2026, also provides recent analyst ratings and financial forecasts for the company. Medpace operates as a full-service clinical contract research organization specializin", "url": "https://www.marketscreener.com/news/medpace-shares-fall-after-jefferies-downgrade-ce7f5ed8dd8ef427", "source_name": "marketscreener.com", "published_at": "2026-07-07T17:13:00", "published_display": "07 Jul 2026 17:13", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies downgrades Medpace stock rating on valuation concerns By Investing.com", "summary": "Jefferies downgraded Medpace Holdings Inc. (NASDAQ:MEDP) to Hold from Buy due to valuation concerns, despite raising its price target to $515.00 from $490.00. The stock is currently trading significantly above this new target, and InvestingPro data indicates it is overvalued, wit", "url": "https://ca.investing.com/news/stock-market-news/jefferies-downgrades-medpace-stock-rating-on-valuation-concerns-93CH-4722284", "source_name": "Investing.com Canada", "published_at": "2026-07-07T08:41:55", "published_display": "07 Jul 2026 08:41", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Stock Outlook Turns on Backlog Quality and Cancellations", "summary": "Medpace Holdings, Inc. (MEDP) faces a near-term outlook where backlog quality and cancellations are more critical than headline growth, despite having stable margins and liquidity. While the company's backlog provides revenue visibility, its book-to-bill ratio remains below 1.0X,", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CRL/pressreleases/3143821/medpace-stock-outlook-turns-on-backlog-quality-and-cancellations/", "source_name": "The Globe and Mail", "published_at": "2026-07-06T15:39:56", "published_display": "06 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock May Be A Bargain On Cash Flow Yet Fully Priced On Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T09:41:46+00:00", "published_display": "05 Jul 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP - Medpace Holdings Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Medpace Holdings Inc (MEDP), along with comprehensive financial data, key performance indicators, and company statistics. It details various financial ratios, insider and institutional ownership, profitability margins, ", "url": "https://finviz.com/stock?t=MEDP&p=d&ty=lf&b=2&page=13", "source_name": "Finviz", "published_at": "2026-07-04T16:41:46", "published_display": "04 Jul 2026 16:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article focuses on the enterprise value to revenue forward metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point presented on TradingView without additional commentary or analysis within the provided content. The surrounding text primarily", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T16:41:46", "published_display": "04 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors", "summary": "Medpace Holdings (NASDAQ:MEDP) has demonstrated strong financial performance, reporting a significant return on capital employed (ROCE) of 34% and increasing its capital employed by 65%. This indicates an efficient and growing business that is effectively reinvesting its earnings", "url": "https://www.moomoo.com/news/post/72466796/here-s-why-medpace-holdings-nasdaq-medp-has-caught-the", "source_name": "Moomoo", "published_at": "2026-07-04T04:39:45", "published_display": "04 Jul 2026 04:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ: MEDP) director converts restricted stock units into common shares", "summary": "Medpace Holdings director Cornelius P. McCarthy III converted 28 restricted stock units (RSUs) into common shares, adding to his direct holdings of 10,352 shares. He still holds 56 unvested RSUs. This transaction, detailed in a Form 4 filing, is an exercise of derivative securiti", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-d53f42fc4285.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:40", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) director converts 36 RSUs into common shares", "summary": "Medpace Holdings director Brian T. Carley converted 36 restricted stock units (RSUs) into common stock on June 30, 2026. This transaction, revealed in a Form 4 SEC filing, brings his total common stock holdings to 32,825 shares, with 71 RSUs remaining. The RSUs are part of a 143-", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-8df98f75ec13.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:40", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) director Robert O. Kraft exercises 33 RSUs, holds 955 shares", "summary": "Medpace Holdings, Inc. director Robert O. Kraft exercised 33 restricted stock units (RSUs) into common shares on June 30, holding 955 common shares and 64 remaining RSUs after the transaction. These RSUs are part of a 130-unit grant from November 28, 2025, vesting in four equal i", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-20ff80778422.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:40", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc", "summary": "Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ:MEDP) and certain officers for alleged violations of federal securities laws. The lawsuit claims Medpace made materially false and misleading statements regarding its ", "url": "https://natlawreview.com/press-releases/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-medpace-7", "source_name": "The National Law Review", "published_at": "2026-07-01T20:39:54", "published_display": "01 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Investors to Connect", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating Medpace Holdings, Inc. (NASDAQ:MEDP) for potential corporate wrongdoing. The firm encourages investors who purchased Medpace securities before April 22, 2025, and still hold them, to connect to assist with the investigation. Thi", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-is-investigating-medpace-hold-1174532", "source_name": "ACCESS Newswire", "published_at": "2026-06-30T16:09:25", "published_display": "30 Jun 2026 16:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Medpace Holdings, Inc. (NASDAQ:MEDP) stockholders who purchased shares before April 22, 2025. The investigation focuses on possible corporate wrongdoing by Medpace and its officers/directors. The la", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-encourages-medpace-holdings-i-1174531", "source_name": "ACCESS Newswire", "published_at": "2026-06-29T15:39:54", "published_display": "29 Jun 2026 15:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This page displays the \"Price to book forward\" metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point provided by TradingView, with additional data from ICE Data Services and FactSet. The page is primarily a placeholder for this specific financi", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:40:55", "published_display": "28 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article provides the \"Price to sales forward\" metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point from TradingView, indicating a specific valuation ratio for the company's stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:40:32", "published_display": "27 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc (MEDP) Valuation: PE, PB & Fair Value Analysis", "summary": "Medpace Holdings Inc (MEDP) has a current valuation score of 9.87, ranking 7th out of 387 in the Biotechnology & Medical Research industry. The company's P/E ratio stands at 32.49, which is significantly below its recent high but above its recent low. However, relevant data for P", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-medp/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-27T08:09:47", "published_display": "27 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article provides financial data for Medpace Holdings, Inc. (NASDAQ: MEDP), specifically focusing on its enterprise value to EBITDA forward metric. The content appears to be a financial data snippet from TradingView, offering a snapshot of this key valuation multiple without ", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T07:09:47", "published_display": "27 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Medpace Holdings, Inc. \u2013 LSX:A2APTV", "summary": "This article provides a financial snapshot of Medpace Holdings, Inc. (LSX:A2APTV) on TradingView, specifically focusing on its forward price-to-earnings ratio. It indicates the market status as closed with no recent trades. The content emphasizes financial data and market informa", "url": "https://www.tradingview.com/symbols/LSX-A2APTV/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:09:05", "published_display": "26 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. Actuals & Estimates (NASDAQ:MEDP)", "summary": "Medpace Holdings, Inc. (MEDP) stock has seen significant growth, with a 1.40% increase in the last 24 hours, 12.29% over the past week, and 65.21% over the last year. Analysts have set a price target range of $400.00 to $495.00 for MEDP. The company is scheduled to release its ne", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:50", "published_display": "26 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Medpace Holdings, Inc. (MEDP) regarding potential claims of corporate wrongdoing by its officers and/or directors. The firm is encouraging investors who purchased Medpace securities before April 22, 2025, and ", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1174530", "source_name": "ACCESS Newswire", "published_at": "2026-06-25T23:40:50", "published_display": "25 Jun 2026 23:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Medpace Holdings, Inc. (NASDAQ: MEDP). The law firm encourages shareholders who purchased Medpace securities before April 22, 2025, and still hold them, to contact them to assi", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/medpace-holdings-inc.-medp-investigation-bronstein-gewirtz-and-g-1174529", "source_name": "ACCESS Newswire", "published_at": "2026-06-24T02:10:44", "published_display": "24 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Medpace Holdings (MEDP) Joining Turtle Creek\u2019s Clinician-Led CRO Portfolio", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Medpace Holdings (MEDP) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONHU1TlJmVU9aVFBqRXk4LTRfN0ZXTVNRQnVKTEZSUTBaLTQtMTZON2RJR0hwaGw5NHYtOTdtMk9HVlJUa3k2bnBMb1hBNVFCbk5ZSWJHY3l5LUlQVFVRVWpLN2dFNGtMLTRBcUxuTHF5Wk5pcFJHa012UWFQYjZGMFpkb1NKWE1nc0xfY1ZPcHhsbDJxcXBjY2pJd0thSlBsV0dKbzBB?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQVS1wX20zcW1FYnV2bFlvU0c1R0NBd3ZzdTlITWRQdHRXQVhzYmE0VUZIOUplbnBOTmxRR1h5Um1hV1FJZy1JTWZrZ3gyeDBVcnZqVnE1bldoMGlwLVVoTDU4Mi1aQW9jdEJPVFBLTUdXVXVtWWNvdmViWUVFTEIyU3M3Y1ROa1VDbGFXSFlUSk9jSnNUaUVwMmVQYVhWQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOVEpBMjdwMkZtdDZyTi1nQUNma1QtMTEzUEdGTEhFdnNoRjl1SUFUSmpSWDV5QzhJeV9ibExvb2hIT0FUWWdGOEdSY2RPTnFtY18wLVNiYXBsQUM3RlFwbk5QTHFMMFp3WEN6T3RjTlVWUHBVUHlVaWdvTzJQSGwwTzQ4WnJNdFVhOWlIYWhucGQ1cjhSOFE1WVFYeGZnN1Rj?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ: MEDP) appoints Brad Hansman as EVP of operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxON1FTdFdWYlB3cU5QV1ZXR1pnQzBOYlgxMHoyckZjb2w4RXZLS0RoMXp1Ty11ZXdEWHZiTHNiQjVteFk3dmdzSlZ5OEszUlQwNzh4dU1PZlVVZTBBLU1nLXlmOTg3S09xaFpMZ1pNLUlLemlEQTFzOGFJWTkxOS1GZnFfdHAzVlc0VVBCMDMxaHNJZTRZWDdUSFZzT3FiMjcwLWFWZUkyS3htU3NGcmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc stock (US5840631062): US class-action deadline and insider trade keep focus on", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQM09yRFpqVGNEbkdSS0p1b20zTUJtc3dhbGJjeENJS2VscTBlak1NeHFsRVJrd2FYWXY4UEVNTkdhVWNlRVk0a1lvczRNOWhIUlliYldBZ1FfUXQzLVZySTRLSnhPMUZfN0oxNE1xNjJBX3AyOG9VSTdfaWVOUzJwYjlUbllLU28wZG5kUEo1RzlyeExQaGRRVG05ZkJITXZOOGx5TklCTVk0MzZad2lMVUlKdlF2bWpyOExwWHRNVlk3eUQ4QVE?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQT3NrZDd3S2NyekJEMjFlSUQ3ZTJxU1Z5SlVCbWZLZkhaSkVzSXViWl9HeFR0aGdncy0yY1VEMHJ1UUNvVWM2NUp5aGZYRTgyNUpoNGE3bmxPd0lFek1lc3lRX1dYYTFuYW5SU1cySFQ3aWhDRi15YllXRVFmblJwRFJqNXdnWnVjR0MtbS11a1BObE9BR2M0M19LSS1tUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP Court Notification: Medpace Cancellation Rates and Corresponding 16% Stock Drop Trigger Shareholder Class Action for Securities Fraud", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxONGZ5MTE3VDdKaktFN3FDbFRPeUlMOFZmaEdpYXFyTTBJR3hiQTNHMXdGU2hxQmJnOUZQY2VoazZjUmtPbDhRbC1ZS3czcDltbk9XNHNlMEFOZ2lpQ2JHc2xHc0F3UmJpYkxhY1FSMHdNUFV1Y1RaOGxYNWdNeTlKdWRKTlFwS01MQmpDaTZFckljbktWNktaUUNKS0RXUGp1cDNCWThkSno2Rm1LQjhRcjh6aXVOTTc5RDFMcm1SSTBfV0NDX2V1ckFBVGNXa2lIa0J0a1BYbVZtaF9yWThtUENlRkkydnpXNU5VWEFaWkhrQnJ5dDhnTDR2MnV5UzNNd2trWGZ2YUVQb3puUUJVMkRGNXBrV090bUVaZg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Medpace Holdings, Inc. (MEDP) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSnRVajVCUkN0aVUxY2Y0MjAxZVhXY0VQdzJhRk12a2tLUWpYTmpHSnNBTmdnRW13aDNuSEV4WFZVeEt1N1RDeFJwdncxRkxMQlB5OE9LNUJkM3pnc2JMT1hLbXppbEVBOVZKU3N4SEtOc2U3bVhmbnAtUFlVeDdqM2o4QzJpb2JNRWxsWjlaR1h5SlZZbWpXZVdvWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Medpace (MEDP) Valuation After Strong Q1 Results And Reaffirmed 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYVR2NTZsejkxS0FfczZTRGEtQVJRWG9rVWZOSjV2NVo4LUpFTDBYbUlkZkYyeUxLUk5GXzNmcEt2TmlCU083WTliWk9NQzBLYVQxNjBkOGlRandsMjF3aGdpLWhoLUwzZWI0UkZvSWhTZUhJenFEMVRGVHhHajFwZmRpbG0wMkdHbkpObHRlR01Xa1o1VjlaTXBLanE5Qlhu?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Margin Slippage Challenges Bullish Narratives Despite Solid Q4 EPS", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Faces Significant Drop in Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORU5IbnZPODFhUGl6NU45S1lTcGNFcW5BcERTOFhoQmozY0F6ck8tbGhlYjdTQ2NHT2tKUkFKbWFsemw2clh6X3MzeG0tWnhRRGtjUUNuMDQ1RXE5UFY1RTRSb2NJN0pyaXgyd1hvNTlnT0V4OEtMLVpyTU51Zm5TckduQy1jbGNVZGFPQjZ4T3ZLVlpxUl8ybUpOUGNNdmNtVTZF?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace\u2019s (NASDAQ:MEDP) Q1 CY2026 Sales Beat Estimates But Stock Drops 19.8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNT1ZkbGFyYVFZQ05wNG1HRm9ZUUtudUx4VldST3dVV2p5WERJS202R1NQc211a3dSTDBLUkk4Z2I5Q21ZejRnWHlYQlRpWHVyQVpockxtWU5SLVBuMUhaSHZ3OGFNc1ZxdC0wdlNRdm42R3VMVlVlLVM2OHE2MnpJeUdWN2ROa3FJNVJ3UXFiaV9jcXdhNlkxVE9vQ1hUOUxUaEFibUpHT3V0eDRadUtQX0VjdEVDcFk2cTd4eXdJNnRzaEw4R1dzeTdub1doeVhnQ0E?oc=5", "source_name": "StockStory", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPZ2hhNkVyM0d6WUZxVlJza3pkNERKUjdVeEZTNDdleHFOZGVESm1NMHNOeGVsVFhJb011azBzWnFvZkdxOUc5OFdHQW5kLUhrZW9mVGlsODNnNmZpc2hyaHFXeFpsczNPLUxNU1BLUm9oV2tBT3ltWEZES1VkeUtSNElwZTlYeFNNMlVlV2tLUEo5cUF0UzJlZ0xHbDhpZ2c?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc. (MEDP) Stock Falls on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdG1sRmtjMTRGUVdVUFc1ODlEbDU5Qi1BZjhXTl93aW1ENVhZWjJXTnloZHBpSkV4NS10ZW5BVUZib1RMdTZyajJ0Q1JZWU4yMjBzMkJCNXdBYlVOSTMzNnNkc3h3Z1g1Q1g1WUlhUVlxbGM4dzI1dWVaQ3otOWNVYXFDUWpRVEVGNmdVUGIyV2QwLWU5V2gyZjEwcmFyUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think \"Yes\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPbWR1V0pyRUFnWnBKejlXOVc2NmZsdFFUZnVvQXQ0ejBBTXgtN1RmT2d0bXdaN2pWODJua2dQUTFnV2VfQjFRdzREOFJBb0VDVjc3bU0ta3hzZUo2Mjh2WnRmTlJSNXZBc3lveFA0MEtBcDg1MUZ6cXRyRW8tQkZpQVFZVk00WkNKSlhNb2NLUHhWSVl1czh4cDVkTUw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Lawsuits And CEO Sales Test Growth Story And Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxNS2Zwc2UxNFdJVHZGS0YxUV9PRk1KbmJyQThqYWpzWS1HSDdqZ1kzNkljdFQ3clVEcHd6ZjZHbkV4dkd6WUVzblFFWmxBZXNWUmlueHV2alB0V1NObHhBVkYtTXFJb01HcEk5ZXBRN1duaGZCWjJ4d3NnVllZMnJLbEJpV3hGcVVUZjVmeVAxRGtRUU1xeFFDcU5qdm9KaWdadjc0cE5MRkl5dG5DVnJnMlgyZzFNVlV6MFFvSS1nWXNRNGRmZEx3c2xyNEZDMXBOWDduVFUzRC1seUtIdXB2Mk1TSmVRZmcxUTNsdnFlMDdyMl9sd2c?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSWVOc08xNUJQc2F5c2NBeVRJQlZ0cDZwY3ZfZkVoVWM1d2JWSTl0X0RyaG9VOVdmQXcxa1BvOG40aDQzeVVDWlNLZktwN2JXTndmRlRaZ01NZjNlbTJkeURxRE1RZlFrUG9RZnhHV3BQRUVTbGNaNm5Vdm9hSm81OFQ2S3U4U0lZMDdFa1paQlNxS25VaklfdTZ4NGRuTXhYZkUxRmIxQkl5cG5mTnNBSmppX3JiYmF2aE1IYjVDNkhpSTR3WkJRX1Noc29ZdnJ3clByd0wzRmczUU9t?oc=5", "source_name": "Business Wire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Laps the Stock Market: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQQXQ4b21HbkNQZXJIb0h3Q3h5NVdOWXdCR0w1RUNLYlg1WmtvdmJmeDY0THpDd2pfNzM3QWltQ2c0YW1BNEJzdkZqRWpydmNOeU1UMXQtZXJtNi1KSHdVLXBoNEloaDJNd3RZQ25DM1VxZks2WjlwbFgwUGFMSFprU3dxWGVNU2EwQnBMY2N5YUlubFQ4cU1UMGhnbw?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings (MEDP) Benefited From GLP-1 Strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPX01jUVV1bGZUalBIMDZ2M2xNNkNVQThoemZiVWNVLUY3a0wtQXdGR2M4WmlOQXptM09QSEt0dUdxeXR3LUZEQXJaS01oOENvZmc2ZWY3UWhjTXRDdVVLY0MweUdrV1A5clIzOEFMcVQ0eWdaajU3YTJESlBBZ3ZiRGttZlNYNERYMEFSRS1sSkJZd1RwYlV0eHk4dHc0aUNWelE?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Medpace (MEDP) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQbGI0N3I2S1J4NFBSbVROdV9rZ0h4b05lX3RiRy1HRTdkcUdoRTNBaFR2RXJ1azgwN3FVSnZLRkFIRTVLN09YZEE5eHUwZ1JyVUxqNWd4dXpfaUlLWDZQa0h6TWVSV1E5V3JkTkpSalY0WTdTNTZETmttc0xvV1luQWxyUnF1ZVpmeHI0NnlDWFBGWU91WDk1cTI4WEc?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Review 2026: ICU Medical vs. Intuitive Surgical vs. Medpace - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNM0RhNGlxVnltcFNaeDQ1cGV0YThXYm1GWmVUVWxocmFUTVh0eFJWSmFDaTJkSE9sbjhrYjNRVUFfTFE2M0h2SDRwZ0pEYld5MjRVRlJlMER0VUN6M2dJei1GbEtRWHdXSzd5LVBhd1FMYmpVQXlVUkRKdDFISDY5b240dWtCTndGcW1Kck1xN0xpb1N6NmJqTkxxWFEtcHZK?oc=5", "source_name": "IndexBox", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPczU1Mi1MWVEwMjVweDRXUGVsUnlnMDJSRFdSeFhtVkFQajd3X2VFcDJrWVRwWFhJdE9aeGp3dEY3N0FZYTZRUjZOVFNoRGg2ZW9DZ1JYMnVhTFZXSHBpT05mOGc4RVloWFIwTi12YVdWODcxMFV5OHJXMEJEY1dhem5sZ3o1RUJmcHpXamUwS2RMZ3RSOUNSR0tYVW1HVjg2WXBkcEt2bUtrQQ?oc=5", "source_name": "TradingView", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Research Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1Zems0TzNFT1hpTThpTk1RcTZJblZqVE9oOFpIVF81cjRlOEMwMm1vYzhYMi1sZ1k5NUx3NXQ3RWVrak1zay1fQVI0eEdOMGdzUDdERXZSYw?oc=5", "source_name": "StockStory", "published_at": "2025-05-06T12:56:32+00:00", "published_display": "06 May 2025 12:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Why Medpace (MEDP) Dipped More Than Broader Market Today", "summary": "Medpace (MEDP) shares dipped 1.49% today, underperforming the broader market, despite an impressive 15.17% gain over the past month. Investors are eagerly anticipating its upcoming earnings report on July 22, 2026, with projected EPS up 31.61% and revenue up 15.95% year-over-year", "url": "https://sg.finance.yahoo.com/news/why-medpace-medp-dipped-more-221505743.html", "source_name": "Market source", "published_at": "2026-07-13T17:15:00", "published_display": "13 Jul 2026 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. (MEDP) Stock Analysis: Is the Current Valuation Justified Amidst Strong Revenue Growth?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxPUk9XWGVmcGdwTUU3dFhObWFFNHFDTGJjZ0RMOW9aanZJbU1EQ2VPM3A0ZlNzaGFhaTJFZ2E4dGhuekE1WkFnUHk2OG1PYnNDODdlbXMwbnRxcno0Y09KWnlGa3RUZzVISDkxQTl0dS02aXo2SnIyaWFsU2ZmVEh5dmJvRUdIbEFnWWtWWFg2Zjhuek5UeUtBcUM0MTBzMU13Y1JxMDRxRGpULWVyaGJXdnZGWVRtenNRLVR2MXVsbmF1dEVIckJNbjVkV01JLXhBR051NUxJMGVxRVlIUWY1Z2x3NEZQYzF6LWlZ?oc=5", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-13T09:24:16+00:00", "published_display": "13 Jul 2026 09:24", "sentiment": "positive", "sentiment_pct": 82, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings (MEDP) Rallies As A More Cautious Narrative Questions The Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQbDJPR1JEWlpESVctMnE3elZEM29mX1U3bGVGSkJnWDJ3c3BsOWVNWjFadDdZNC1HZi1yQUl0bVIyMExibFhwWUJiSU80VEJiQkJ1VnN2QWdfLXZfSXJuVTVpcUNFaXZIVzFSQkNMaW5QU2UyM09qdmNXZzhIY3FNRUZoRmEzZmsxbllGVFE0eTVTd2FhSDZvMTJpMi02Y24w?oc=5", "source_name": "Market source", "published_at": "2026-07-11T06:14:00+00:00", "published_display": "11 Jul 2026 06:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Medpace Holdings, Inc. (MEDP) regarding potential corporate wrongdoing. The firm is encouraging shareholders who purchased Medpace securities prior to April 22, 2025, and still hold them, to join the investigat", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1174536", "source_name": "ACCESS Newswire", "published_at": "2026-07-09T11:00:00", "published_display": "09 Jul 2026 11:00", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird downgrades Medpace stock rating to neutral, raises target to $547", "summary": "Baird has downgraded Medpace Holdings Inc. (NASDAQ:MEDP) from Outperform to Neutral, while increasing its price target to $547.00 from $477.00. The downgrade comes despite the stock's 69% surge over the past year, as its current trading price of $546 is nearly identical to Baird'", "url": "https://www.investing.com/news/analyst-ratings/baird-downgrades-medpace-stock-rating-to-neutral-raises-target-to-547-93CH-4780801", "source_name": "Investing.com", "published_at": "2026-07-09T06:39:40", "published_display": "09 Jul 2026 06:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Shares Fall After Baird Downgrade", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/medpace-shares-fall-baird-downgrade-190643265.html", "source_name": "MT Newswires", "published_at": "2026-07-08T19:06:43+00:00", "published_display": "08 Jul 2026 19:06", "sentiment": "negative", "sentiment_pct": 22, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird downgrades Medpace stock rating to neutral, raises target to $547 By Investing.com", "summary": "Baird has downgraded Medpace (NASDAQ:MEDP) stock from Outperform to Neutral, while increasing its price target to $547 from $477. The downgrade is primarily due to the stock's significant rally, now trading near Baird's new price target, and a need for the firm to substantially r", "url": "https://ng.investing.com/news/stock-market-news/baird-downgrades-medpace-stock-rating-to-neutral-raises-target-to-547-93CH-2590291", "source_name": "Investing.com Nigeria", "published_at": "2026-07-08T16:11:21", "published_display": "08 Jul 2026 16:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Downgrades Medpace to Neutral From Outperform, Adjusts PT to $547 From $477", "summary": "Baird has downgraded Medpace Holdings (MEDP) from an \"Outperform\" rating to \"Neutral,\" while simultaneously increasing its price target for the company from $477 to $547. This adjustment reflects a modified outlook by the firm on Medpace's stock. The article also provides a brief", "url": "https://www.marketscreener.com/news/baird-downgrades-medpace-to-neutral-from-outperform-adjusts-pt-to-547-from-477-ce7f5ed9d980f123", "source_name": "marketscreener.com", "published_at": "2026-07-08T12:10:58", "published_display": "08 Jul 2026 12:10", "sentiment": "negative", "sentiment_pct": 38, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Can Medpace Holdings (MEDP) Justify Its Valuation On Backlog Quality Concerns?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-08T06:46:19+00:00", "published_display": "08 Jul 2026 06:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Growth Trends Show How CRO Demand Is Shifting in 2026", "summary": "Medpace Holdings (MEDP) is experiencing a shift in demand for its clinical research organization (CRO) services in 2026, with an uneven distribution across therapeutic areas and a longer conversion cycle for awards into revenue. Despite these challenges, Medpace's full-service mo", "url": "https://www.theglobeandmail.com/investing/markets/stocks/MEDP/pressreleases/3165471/medpace-growth-trends-show-how-cro-demand-is-shifting-in-2026/", "source_name": "The Globe and Mail", "published_at": "2026-07-07T18:39:43", "published_display": "07 Jul 2026 18:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies downgrades Medpace stock rating on valuation concerns", "summary": "Jefferies downgraded Medpace Holdings Inc. (NASDAQ:MEDP) to Hold from Buy, citing significant valuation concerns despite raising the price target to $515.00 from $490.00. The stock is currently trading above this target, and analysts note it is overvalued, with several downward e", "url": "https://www.investing.com/news/analyst-ratings/jefferies-downgrades-medpace-stock-rating-on-valuation-concerns-93CH-4778382", "source_name": "Investing.com", "published_at": "2026-07-07T18:10:14", "published_display": "07 Jul 2026 18:10", "sentiment": "negative", "sentiment_pct": 26, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Shares Fall After Jefferies Downgrade", "summary": "Medpace Holdings, Inc. shares dropped following a downgrade from Jefferies. The article, published on July 7, 2026, also provides recent analyst ratings and financial forecasts for the company. Medpace operates as a full-service clinical contract research organization specializin", "url": "https://www.marketscreener.com/news/medpace-shares-fall-after-jefferies-downgrade-ce7f5ed8dd8ef427", "source_name": "marketscreener.com", "published_at": "2026-07-07T17:13:00", "published_display": "07 Jul 2026 17:13", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Jefferies downgrades Medpace stock rating on valuation concerns By Investing.com", "summary": "Jefferies downgraded Medpace Holdings Inc. (NASDAQ:MEDP) to Hold from Buy due to valuation concerns, despite raising its price target to $515.00 from $490.00. The stock is currently trading significantly above this new target, and InvestingPro data indicates it is overvalued, wit", "url": "https://ca.investing.com/news/stock-market-news/jefferies-downgrades-medpace-stock-rating-on-valuation-concerns-93CH-4722284", "source_name": "Investing.com Canada", "published_at": "2026-07-07T08:41:55", "published_display": "07 Jul 2026 08:41", "sentiment": "negative", "sentiment_pct": 29, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Stock Outlook Turns on Backlog Quality and Cancellations", "summary": "Medpace Holdings, Inc. (MEDP) faces a near-term outlook where backlog quality and cancellations are more critical than headline growth, despite having stable margins and liquidity. While the company's backlog provides revenue visibility, its book-to-bill ratio remains below 1.0X,", "url": "https://www.theglobeandmail.com/investing/markets/stocks/CRL/pressreleases/3143821/medpace-stock-outlook-turns-on-backlog-quality-and-cancellations/", "source_name": "The Globe and Mail", "published_at": "2026-07-06T15:39:56", "published_display": "06 Jul 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock May Be A Bargain On Cash Flow Yet Fully Priced On Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T09:41:46+00:00", "published_display": "05 Jul 2026 09:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP - Medpace Holdings Inc Latest SEC Filings", "summary": "This article provides the latest SEC filings information for Medpace Holdings Inc (MEDP), along with comprehensive financial data, key performance indicators, and company statistics. It details various financial ratios, insider and institutional ownership, profitability margins, ", "url": "https://finviz.com/stock?t=MEDP&p=d&ty=lf&b=2&page=13", "source_name": "Finviz", "published_at": "2026-07-04T16:41:46", "published_display": "04 Jul 2026 16:41", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article focuses on the enterprise value to revenue forward metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point presented on TradingView without additional commentary or analysis within the provided content. The surrounding text primarily", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-04T16:41:46", "published_display": "04 Jul 2026 16:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Medpace Holdings (NASDAQ:MEDP) Has Caught The Eye Of Investors", "summary": "Medpace Holdings (NASDAQ:MEDP) has demonstrated strong financial performance, reporting a significant return on capital employed (ROCE) of 34% and increasing its capital employed by 65%. This indicates an efficient and growing business that is effectively reinvesting its earnings", "url": "https://www.moomoo.com/news/post/72466796/here-s-why-medpace-holdings-nasdaq-medp-has-caught-the", "source_name": "Moomoo", "published_at": "2026-07-04T04:39:45", "published_display": "04 Jul 2026 04:39", "sentiment": "positive", "sentiment_pct": 77, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ: MEDP) director converts restricted stock units into common shares", "summary": "Medpace Holdings director Cornelius P. McCarthy III converted 28 restricted stock units (RSUs) into common shares, adding to his direct holdings of 10,352 shares. He still holds 56 unvested RSUs. This transaction, detailed in a Form 4 filing, is an exercise of derivative securiti", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-d53f42fc4285.html", "source_name": "Stock Titan", "published_at": "2026-07-02T20:40:40", "published_display": "02 Jul 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) director converts 36 RSUs into common shares", "summary": "Medpace Holdings director Brian T. Carley converted 36 restricted stock units (RSUs) into common stock on June 30, 2026. This transaction, revealed in a Form 4 SEC filing, brings his total common stock holdings to 32,825 shares, with 71 RSUs remaining. The RSUs are part of a 143-", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-8df98f75ec13.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:40", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) director Robert O. Kraft exercises 33 RSUs, holds 955 shares", "summary": "Medpace Holdings, Inc. director Robert O. Kraft exercised 33 restricted stock units (RSUs) into common shares on June 30, holding 955 common shares and 64 remaining RSUs after the transaction. These RSUs are part of a 130-unit grant from November 28, 2025, vesting in four equal i", "url": "https://www.stocktitan.net/sec-filings/MEDP/form-4-medpace-holdings-inc-insider-trading-activity-20ff80778422.html", "source_name": "Stock Titan", "published_at": "2026-07-02T19:40:40", "published_display": "02 Jul 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc", "summary": "Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Medpace Holdings, Inc. (NASDAQ:MEDP) and certain officers for alleged violations of federal securities laws. The lawsuit claims Medpace made materially false and misleading statements regarding its ", "url": "https://natlawreview.com/press-releases/medp-investor-alert-bronstein-gewirtz-and-grossman-llc-announces-medpace-7", "source_name": "The National Law Review", "published_at": "2026-07-01T20:39:54", "published_display": "01 Jul 2026 20:39", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Investors to Connect", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating Medpace Holdings, Inc. (NASDAQ:MEDP) for potential corporate wrongdoing. The firm encourages investors who purchased Medpace securities before April 22, 2025, and still hold them, to connect to assist with the investigation. Thi", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-is-investigating-medpace-hold-1174532", "source_name": "ACCESS Newswire", "published_at": "2026-06-30T16:09:25", "published_display": "30 Jun 2026 16:09", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP) Stockholders to Inquire about Securities Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of Medpace Holdings, Inc. (NASDAQ:MEDP) stockholders who purchased shares before April 22, 2025. The investigation focuses on possible corporate wrongdoing by Medpace and its officers/directors. The la", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-encourages-medpace-holdings-i-1174531", "source_name": "ACCESS Newswire", "published_at": "2026-06-29T15:39:54", "published_display": "29 Jun 2026 15:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This page displays the \"Price to book forward\" metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point provided by TradingView, with additional data from ICE Data Services and FactSet. The page is primarily a placeholder for this specific financi", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T14:40:55", "published_display": "28 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article provides the \"Price to sales forward\" metric for Medpace Holdings, Inc. (NASDAQ: MEDP). It appears to be a financial data point from TradingView, indicating a specific valuation ratio for the company's stock.", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:40:32", "published_display": "27 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc (MEDP) Valuation: PE, PB & Fair Value Analysis", "summary": "Medpace Holdings Inc (MEDP) has a current valuation score of 9.87, ranking 7th out of 387 in the Biotechnology & Medical Research industry. The company's P/E ratio stands at 32.49, which is significantly below its recent high but above its recent low. However, relevant data for P", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-medp/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-27T08:09:47", "published_display": "27 Jun 2026 08:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBITDA forward of Medpace Holdings, Inc. \u2013 NASDAQ:MEDP", "summary": "This article provides financial data for Medpace Holdings, Inc. (NASDAQ: MEDP), specifically focusing on its enterprise value to EBITDA forward metric. The content appears to be a financial data snippet from TradingView, offering a snapshot of this key valuation multiple without ", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/financials-statistics-and-ratios/enterprise-value-ebitda-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T07:09:47", "published_display": "27 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Medpace Holdings, Inc. \u2013 LSX:A2APTV", "summary": "This article provides a financial snapshot of Medpace Holdings, Inc. (LSX:A2APTV) on TradingView, specifically focusing on its forward price-to-earnings ratio. It indicates the market status as closed with no recent trades. The content emphasizes financial data and market informa", "url": "https://www.tradingview.com/symbols/LSX-A2APTV/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T23:09:05", "published_display": "26 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. Actuals & Estimates (NASDAQ:MEDP)", "summary": "Medpace Holdings, Inc. (MEDP) stock has seen significant growth, with a 1.40% increase in the last 24 hours, 12.29% over the past week, and 65.21% over the last year. Analysts have set a price target range of $400.00 to $495.00 for MEDP. The company is scheduled to release its ne", "url": "https://www.tradingview.com/symbols/NASDAQ-MEDP/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T08:40:50", "published_display": "26 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Investors to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Medpace Holdings, Inc. (MEDP) regarding potential claims of corporate wrongdoing by its officers and/or directors. The firm is encouraging investors who purchased Medpace securities before April 22, 2025, and ", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/bronstein-gewirtz-and-grossman-llc-announces-an-investigation-ag-1174530", "source_name": "ACCESS Newswire", "published_at": "2026-06-25T23:40:50", "published_display": "25 Jun 2026 23:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation", "summary": "Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Medpace Holdings, Inc. (NASDAQ: MEDP). The law firm encourages shareholders who purchased Medpace securities before April 22, 2025, and still hold them, to contact them to assi", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/medpace-holdings-inc.-medp-investigation-bronstein-gewirtz-and-g-1174529", "source_name": "ACCESS Newswire", "published_at": "2026-06-24T02:10:44", "published_display": "24 Jun 2026 02:10", "sentiment": "negative", "sentiment_pct": 29, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Medpace Holdings (MEDP) Joining Turtle Creek\u2019s Clinician-Led CRO Portfolio", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What Makes Medpace Holdings (MEDP) an Investment Bet?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxONHU1TlJmVU9aVFBqRXk4LTRfN0ZXTVNRQnVKTEZSUTBaLTQtMTZON2RJR0hwaGw5NHYtOTdtMk9HVlJUa3k2bnBMb1hBNVFCbk5ZSWJHY3l5LUlQVFVRVWpLN2dFNGtMLTRBcUxuTHF5Wk5pcFJHa012UWFQYjZGMFpkb1NKWE1nc0xfY1ZPcHhsbDJxcXBjY2pJd0thSlBsV0dKbzBB?oc=5", "source_name": "Market source", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQVS1wX20zcW1FYnV2bFlvU0c1R0NBd3ZzdTlITWRQdHRXQVhzYmE0VUZIOUplbnBOTmxRR1h5Um1hV1FJZy1JTWZrZ3gyeDBVcnZqVnE1bldoMGlwLVVoTDU4Mi1aQW9jdEJPVFBLTUdXVXVtWWNvdmViWUVFTEIyU3M3Y1ROa1VDbGFXSFlUSk9jSnNUaUVwMmVQYVhWQQ?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock Weighing Modest Undervaluation Against Rich P/E And Mixed Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxOVEpBMjdwMkZtdDZyTi1nQUNma1QtMTEzUEdGTEhFdnNoRjl1SUFUSmpSWDV5QzhJeV9ibExvb2hIT0FUWWdGOEdSY2RPTnFtY18wLVNiYXBsQUM3RlFwbk5QTHFMMFp3WEN6T3RjTlVWUHBVUHlVaWdvTzJQSGwwTzQ4WnJNdFVhOWlIYWhucGQ1cjhSOFE1WVFYeGZnN1Rj?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ: MEDP) appoints Brad Hansman as EVP of operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxON1FTdFdWYlB3cU5QV1ZXR1pnQzBOYlgxMHoyckZjb2w4RXZLS0RoMXp1Ty11ZXdEWHZiTHNiQjVteFk3dmdzSlZ5OEszUlQwNzh4dU1PZlVVZTBBLU1nLXlmOTg3S09xaFpMZ1pNLUlLemlEQTFzOGFJWTkxOS1GZnFfdHAzVlc0VVBCMDMxaHNJZTRZWDdUSFZzT3FiMjcwLWFWZUkyS3htU3NGcmc?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc stock (US5840631062): US class-action deadline and insider trade keep focus on", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQM09yRFpqVGNEbkdSS0p1b20zTUJtc3dhbGJjeENJS2VscTBlak1NeHFsRVJrd2FYWXY4UEVNTkdhVWNlRVk0a1lvczRNOWhIUlliYldBZ1FfUXQzLVZySTRLSnhPMUZfN0oxNE1xNjJBX3AyOG9VSTdfaWVOUzJwYjlUbllLU28wZG5kUEo1RzlyeExQaGRRVG05ZkJITXZOOGx5TklCTVk0MzZad2lMVUlKdlF2bWpyOExwWHRNVlk3eUQ4QVE?oc=5", "source_name": "Ad Hoc News", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Stock Slides as Market Rises: Facts to Know Before You Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQT3NrZDd3S2NyekJEMjFlSUQ3ZTJxU1Z5SlVCbWZLZkhaSkVzSXViWl9HeFR0aGdncy0yY1VEMHJ1UUNvVWM2NUp5aGZYRTgyNUpoNGE3bmxPd0lFek1lc3lRX1dYYTFuYW5SU1cySFQ3aWhDRi15YllXRVFmblJwRFJqNXdnWnVjR0MtbS11a1BObE9BR2M0M19LSS1tUQ?oc=5", "source_name": "Market source", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "MEDP Court Notification: Medpace Cancellation Rates and Corresponding 16% Stock Drop Trigger Shareholder Class Action for Securities Fraud", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAJBVV95cUxONGZ5MTE3VDdKaktFN3FDbFRPeUlMOFZmaEdpYXFyTTBJR3hiQTNHMXdGU2hxQmJnOUZQY2VoazZjUmtPbDhRbC1ZS3czcDltbk9XNHNlMEFOZ2lpQ2JHc2xHc0F3UmJpYkxhY1FSMHdNUFV1Y1RaOGxYNWdNeTlKdWRKTlFwS01MQmpDaTZFckljbktWNktaUUNKS0RXUGp1cDNCWThkSno2Rm1LQjhRcjh6aXVOTTc5RDFMcm1SSTBfV0NDX2V1ckFBVGNXa2lIa0J0a1BYbVZtaF9yWThtUENlRkkydnpXNU5VWEFaWkhrQnJ5dDhnTDR2MnV5UzNNd2trWGZ2YUVQb3puUUJVMkRGNXBrV090bUVaZg?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Medpace Holdings, Inc. (MEDP) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSnRVajVCUkN0aVUxY2Y0MjAxZVhXY0VQdzJhRk12a2tLUWpYTmpHSnNBTmdnRW13aDNuSEV4WFZVeEt1N1RDeFJwdncxRkxMQlB5OE9LNUJkM3pnc2JMT1hLbXppbEVBOVZKU3N4SEtOc2U3bVhmbnAtUFlVeDdqM2o4QzJpb2JNRWxsWjlaR1h5SlZZbWpXZVdvWQ?oc=5", "source_name": "Market source", "published_at": "2026-05-03T07:00:00+00:00", "published_display": "03 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Medpace (MEDP) Valuation After Strong Q1 Results And Reaffirmed 2026 Revenue Guidance", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxPYVR2NTZsejkxS0FfczZTRGEtQVJRWG9rVWZOSjV2NVo4LUpFTDBYbUlkZkYyeUxLUk5GXzNmcEt2TmlCU083WTliWk9NQzBLYVQxNjBkOGlRandsMjF3aGdpLWhoLUwzZWI0UkZvSWhTZUhJenFEMVRGVHhHajFwZmRpbG0wMkdHbkpObHRlR01Xa1o1VjlaTXBLanE5Qlhu?oc=5", "source_name": "Market source", "published_at": "2026-04-28T07:00:00+00:00", "published_display": "28 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings, Inc. Just Beat EPS By 10%: Here's What Analysts Think Will Happen Next", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Margin Slippage Challenges Bullish Narratives Despite Solid Q4 EPS", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Faces Significant Drop in Stock Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxORU5IbnZPODFhUGl6NU45S1lTcGNFcW5BcERTOFhoQmozY0F6ck8tbGhlYjdTQ2NHT2tKUkFKbWFsemw2clh6X3MzeG0tWnhRRGtjUUNuMDQ1RXE5UFY1RTRSb2NJN0pyaXgyd1hvNTlnT0V4OEtMLVpyTU51Zm5TckduQy1jbGNVZGFPQjZ4T3ZLVlpxUl8ybUpOUGNNdmNtVTZF?oc=5", "source_name": "GuruFocus", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace\u2019s (NASDAQ:MEDP) Q1 CY2026 Sales Beat Estimates But Stock Drops 19.8%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNT1ZkbGFyYVFZQ05wNG1HRm9ZUUtudUx4VldST3dVV2p5WERJS202R1NQc211a3dSTDBLUkk4Z2I5Q21ZejRnWHlYQlRpWHVyQVpockxtWU5SLVBuMUhaSHZ3OGFNc1ZxdC0wdlNRdm42R3VMVlVlLVM2OHE2MnpJeUdWN2ROa3FJNVJ3UXFiaV9jcXdhNlkxVE9vQ1hUOUxUaEFibUpHT3V0eDRadUtQX0VjdEVDcFk2cTd4eXdJNnRzaEw4R1dzeTdub1doeVhnQ0E?oc=5", "source_name": "StockStory", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPZ2hhNkVyM0d6WUZxVlJza3pkNERKUjdVeEZTNDdleHFOZGVESm1NMHNOeGVsVFhJb011azBzWnFvZkdxOUc5OFdHQW5kLUhrZW9mVGlsODNnNmZpc2hyaHFXeFpsczNPLUxNU1BLUm9oV2tBT3ltWEZES1VkeUtSNElwZTlYeFNNMlVlV2tLUEo5cUF0UzJlZ0xHbDhpZ2c?oc=5", "source_name": "Market source", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings Inc. (MEDP) Stock Falls on Q1 2026 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxNdG1sRmtjMTRGUVdVUFc1ODlEbDU5Qi1BZjhXTl93aW1ENVhZWjJXTnloZHBpSkV4NS10ZW5BVUZib1RMdTZyajJ0Q1JZWU4yMjBzMkJCNXdBYlVOSTMzNnNkc3h3Z1g1Q1g1WUlhUVlxbGM4dzI1dWVaQ3otOWNVYXFDUWpRVEVGNmdVUGIyV2QwLWU5V2gyZjEwcmFyUQ?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Medpace (MEDP) a Solid Growth Stock? 3 Reasons to Think \"Yes\"", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxPbWR1V0pyRUFnWnBKejlXOVc2NmZsdFFUZnVvQXQ0ejBBTXgtN1RmT2d0bXdaN2pWODJua2dQUTFnV2VfQjFRdzREOFJBb0VDVjc3bU0ta3hzZUo2Mjh2WnRmTlJSNXZBc3lveFA0MEtBcDg1MUZ6cXRyRW8tQkZpQVFZVk00WkNKSlhNb2NLUHhWSVl1czh4cDVkTUw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Lawsuits And CEO Sales Test Growth Story And Valuation", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-12T07:00:00+00:00", "published_display": "12 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shareholders who lost money in Medpace Holdings, Inc. (NASDAQ: MEDP) Should Contact Wolf Haldenstein Immediately", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9gFBVV95cUxNS2Zwc2UxNFdJVHZGS0YxUV9PRk1KbmJyQThqYWpzWS1HSDdqZ1kzNkljdFQ3clVEcHd6ZjZHbkV4dkd6WUVzblFFWmxBZXNWUmlueHV2alB0V1NObHhBVkYtTXFJb01HcEk5ZXBRN1duaGZCWjJ4d3NnVllZMnJLbEJpV3hGcVVUZjVmeVAxRGtRUU1xeFFDcU5qdm9KaWdadjc0cE5MRkl5dG5DVnJnMlgyZzFNVlV6MFFvSS1nWXNRNGRmZEx3c2xyNEZDMXBOWDduVFUzRC1seUtIdXB2Mk1TSmVRZmcxUTNsdnFlMDdyMl9sd2c?oc=5", "source_name": "PR Newswire", "published_at": "2026-04-10T07:00:00+00:00", "published_display": "10 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Investor Notice: Robbins LLP Informs Investors of the Medpace Holdings Inc. Class Action", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSWVOc08xNUJQc2F5c2NBeVRJQlZ0cDZwY3ZfZkVoVWM1d2JWSTl0X0RyaG9VOVdmQXcxa1BvOG40aDQzeVVDWlNLZktwN2JXTndmRlRaZ01NZjNlbTJkeURxRE1RZlFrUG9RZnhHV3BQRUVTbGNaNm5Vdm9hSm81OFQ2S3U4U0lZMDdFa1paQlNxS25VaklfdTZ4NGRuTXhYZkUxRmIxQkl5cG5mTnNBSmppX3JiYmF2aE1IYjVDNkhpSTR3WkJRX1Noc29ZdnJ3clByd0wzRmczUU9t?oc=5", "source_name": "Business Wire", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Laps the Stock Market: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxQQXQ4b21HbkNQZXJIb0h3Q3h5NVdOWXdCR0w1RUNLYlg1WmtvdmJmeDY0THpDd2pfNzM3QWltQ2c0YW1BNEJzdkZqRWpydmNOeU1UMXQtZXJtNi1KSHdVLXBoNEloaDJNd3RZQ25DM1VxZks2WjlwbFgwUGFMSFprU3dxWGVNU2EwQnBMY2N5YUlubFQ4cU1UMGhnbw?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace Holdings (MEDP) Benefited From GLP-1 Strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPX01jUVV1bGZUalBIMDZ2M2xNNkNVQThoemZiVWNVLUY3a0wtQXdGR2M4WmlOQXptM09QSEt0dUdxeXR3LUZEQXJaS01oOENvZmc2ZWY3UWhjTXRDdVVLY0MweUdrV1A5clIzOEFMcVQ0eWdaajU3YTJESlBBZ3ZiRGttZlNYNERYMEFSRS1sSkJZd1RwYlV0eHk4dHc0aUNWelE?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Medpace (MEDP) Outpaced the Stock Market Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQbGI0N3I2S1J4NFBSbVROdV9rZ0h4b05lX3RiRy1HRTdkcUdoRTNBaFR2RXJ1azgwN3FVSnZLRkFIRTVLN09YZEE5eHUwZ1JyVUxqNWd4dXpfaUlLWDZQa0h6TWVSV1E5V3JkTkpSalY0WTdTNTZETmttc0xvV1luQWxyUnF1ZVpmeHI0NnlDWFBGWU91WDk1cTI4WEc?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Healthcare Stocks Review 2026: ICU Medical vs. Intuitive Surgical vs. Medpace - News and Statistics", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNM0RhNGlxVnltcFNaeDQ1cGV0YThXYm1GWmVUVWxocmFUTVh0eFJWSmFDaTJkSE9sbjhrYjNRVUFfTFE2M0h2SDRwZ0pEYld5MjRVRlJlMER0VUN6M2dJei1GbEtRWHdXSzd5LVBhd1FMYmpVQXlVUkRKdDFISDY5b240dWtCTndGcW1Kck1xN0xpb1N6NmJqTkxxWFEtcHZK?oc=5", "source_name": "IndexBox", "published_at": "2026-03-09T07:00:00+00:00", "published_display": "09 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (NASDAQ:MEDP) Reports Bullish Q4 CY2025", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPczU1Mi1MWVEwMjVweDRXUGVsUnlnMDJSRFdSeFhtVkFQajd3X2VFcDJrWVRwWFhJdE9aeGp3dEY3N0FZYTZRUjZOVFNoRGg2ZW9DZ1JYMnVhTFZXSHBpT05mOGc4RVloWFIwTi12YVdWODcxMFV5OHJXMEJEY1dhem5sZ3o1RUJmcHpXamUwS2RMZ3RSOUNSR0tYVW1HVjg2WXBkcEt2bUtrQQ?oc=5", "source_name": "TradingView", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medpace (MEDP) Research Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMiV0FVX3lxTE1Zems0TzNFT1hpTThpTk1RcTZJblZqVE9oOFpIVF81cjRlOEMwMm1vYzhYMi1sZ1k5NUx3NXQ3RWVrak1zay1fQVI0eEdOMGdzUDdERXZSYw?oc=5", "source_name": "StockStory", "published_at": "2025-05-06T12:56:32+00:00", "published_display": "06 May 2025 12:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 106, "total_relevant": 58, "sentiment_summary": {"positive": 14, "negative": 14, "neutral": 30, "score": 48, "total": 58, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 15.95, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 7.15, "count": 13}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 4.4, "count": 8}, {"event": "analyst", "label": "Analyst action", "weight": 4.4, "count": 8}], "positive_events": 14, "negative_events": 14}, "market_context": {"has_market_context": true, "latest_close": 538.23, "latest_week": "2026-07-10", "one_week_move": -3.5, "four_week_move": 15.2, "twelve_week_move": 3.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.816598, "market_dynamics_buy_signal": false, "relative_strength": -8.128007, "fair_value_gap": 38.9, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 62.1735, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.5% over one week, +15.2% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 13}, {"label": "TradingView", "count": 7}, {"label": "simplywall.st", "count": 6}, {"label": "ACCESS Newswire", "count": 5}, {"label": "Stock Titan", "count": 4}, {"label": "Investing.com", "count": 2}, {"label": "marketscreener.com", "count": 2}, {"label": "The Globe and Mail", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 58}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 13}, {"label": "Regulatory and legal", "count": 8}, {"label": "Analyst action", "count": 8}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "58", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.5% over one week, +15.2% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Why Medpace (MEDP) Dipped More Than Broader Market Today"}], "updated_at": "2026-07-16T08:12:45.790003+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}